Risks »
Pfizer DPA: New Minimum Best Practices for FCPA Compliance Programs?
Last week was wild in the Foreign Corrupt Practices Act (FCPA) and wider compliance world. In the FCPA arena, as most compliance practitioners are aware, Pfizer settled its FCPA enforcement action this week. In
Read More »Pfizer pays $60 million to settle bribery charges
Pfizer has agreed to pay the federal government $60 million to settle allegations that its employees bribed doctors and other foreign officials in Europe and Asia to win business and boost sales.
Read More »More Asian nations passing own anti-corruption laws, says report
Several Asian jurisdictions have passed legislation similar to the U.S. Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act (UKBA) in recent years as part of a bid to ensure the operations of
Read More »Export Controls and Sanctions: Stealing the Enforcement Limelight?
The Justice Department always touts its FCPA, Criminal Antitrust and Health Care Fraud enforcement programs. It is very proud of its record in these areas. But quietly and methodically the Justice Department
Read More »High Tide: From U.K. Umbrage to Australian Cover-up Allegations
Transparency International accused the Reserve Bank of Australia of covering up bribery by its currency note-printing business. Though no RBA officials or staff have been charged, allegations of suppressing evidence have been swirling. The
Read More »How To Resist A Bribe In International Transactions
Compliance programmes covering corruption and anti bribery among companies doing business in Sub Sahara Africa are becoming common. A problem still exists, however, when bidding for projects or conducting daily business. Solicitation from
Read More »Anti-Money Laundering For the Non-Banking Entity
While many companies which operate under anti-bribery laws such as the UK Bribery Act or anti-corruption laws such as the US Foreign Corrupt Practices Act (FCPA), have compliance programs in place to review business
Read More »Navigating Corruption Risks in China
The FCPA paparazzi like to wring its hands over anti-corruption compliance in China. Some of the wringing makes sense; some does not. No company should avoid entering or expanding into China because of corruption
Read More »